Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OncoPrecision logo — Leveraging single-cell high-throughput biology and AI/ML to...

OncoPrecision

Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.

Founded 2020 United States New York, United States 32 employees Convertible Note Total: $4.16M Biotechnology, Health and Wellness

General Information

Company Name OncoPrecision
Founded Year 2020
Location United States New York, United States
Founders / Decision Makers
Team member
Employees 32
Industries Biotechnology, Health and Wellness
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with OncoPrecision. To contact OncoPrecision, visit oncoprecision.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About OncoPrecision

OncoPrecision is a biotechnology startup founded in 2020 and headquartered in the United States. The company's slogan, "Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy," succinctly captures its mission. OncoPrecision received a Convertible Note investment on 20 June 2024 from SOSV and indiebio. The startup operates within the Biotechnology and Health and Wellness industries. The integration of cutting-edge technology with the life-saving mission of improving cancer therapy positions OncoPrecision as a promising player in the biotech space with the potential to revolutionize cancer treatment outcomes.

Taxonomy: cancer treatment, precision medicine, oncology, pharmaceutical research, ex-vivo testing, personalized medicine, clinical trials, patient-specific treatment

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
20 Jun 2024
Seed Round $3.31M 7
SOSV Creative Ventures indiebio
SOSV, Creative Ventures +5
01 Aug 2022
Pre Seed Round $850.00K 1
SOSV
SOSV
01 Mar 2020

OncoPrecision Alternatives & Competitors

View All Alternatives
OncoPrecision vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
OncoPrecision vs
Fresh Wind Biotechnologies
Fresh Wind Biotechnologies United States

Transforming cancer therapeutics with cutting-edge immunotherapy

Series A
2 employees
Biotechnology, Health and Wellness
OncoPrecision vs
Lantern Pharma Inc. (Nasdaq: LTRN)
Lantern Pharma Inc. (Nasdaq: LTRN) United States

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Post-IPO Secondary
28 employees
AI, Biopharma
View all alternatives

FAQ About OncoPrecision

Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.
OncoPrecision was founded in 2020.
OncoPrecision is headquartered in New York, United States.
OncoPrecision operates in Biotechnology and Health and Wellness. Its work centres on cancer treatment, precision medicine, oncology and pharmaceutical research.
OncoPrecision has approximately 32 employees.
OncoPrecision has completed 3 funding rounds, raising a total of $4.16M. The latest funding stage is Convertible Note.
Top alternatives and competitors to OncoPrecision include Prescient Therapeutics, Fresh Wind Biotechnologies, Lantern Pharma Inc. (Nasdaq: LTRN), Epitopea, Refuge Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OncoPrecision and Prescient Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OncoPrecision, https://bouncewatch.com/company/oncoprecision, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes